Natural regulatory T cells in patients with chronic hepatitis C genotype 1 treated by pegylated interferon and ribavirin
SHAO Xiao-qiong,ZHAO Zhi-xin,CAI Qing-xian,ZHANG Xiao-hong,LIN Chao-shuang,GAO Zhi-liang
2012-01-01
Journal of Tropical Medicine
Abstract:Objective To explore the alteration of circulating natural regulatory T cells(nTregs) in patients with chronic hepatitis C genotype 1 during pegylated interferon /ribavirin combination therapy and its clinical significance.Methods 32 chronic hepatitis C naive patients who had high viral titers of HCV genotype 1 and were treated with pegylated interferon plus ribavirin.Blood samples were collected at pre-treatment,week 2,week 4,week 8,week 12,week 24 and week 48 during therapy,and at week 12 or 24 of follow-up after termination of therapy.The frequency of CD4(+)CD25(+)Foxp3(+)Tregs in peripheral blood mononuclear cells(PBMCs) was determined by flow cytometry.HCV-RNA was detected by Roche COBAS Ampliprep /COBAS Taqman HCV test.Results 24 patients with undetectable HCV-RNA at treatment week 12 achieved sustained virologic response(SVR).8 patients with detectable HCV RNA at week 12 failed to achieve virologic response at week 24 and discontinue the treatment at week 24.There was no significant difference in the frequency of CD4(+)CD25(+)Foxp3(+)Tregs in PBMCs(P >0.05) at pre-treatment between the response group and nonresponse group.The frequencies of CD4(+)CD25(+)Foxp3(+) Tregs in PBMCs from the response group at week 2,week 4,week 12,week 24 and week 48 during therapy,and at follow-up were(0.91±0.22)%,(1.31±0.29)%,(1.78± 0.43)%,(1.92±0.44)%,(1.90±0.37)%,(1.14±0.35)%,respectively,obviously decreased at week 2(P<0.001) and at follow-up(P>0.05) and increased at week 4(P<0.001) and 12(P<0.001) as regard to previous adjacent time points.The frequencies of CD4(+)CD25(+)Foxp3(+) Tregs in PBMCs from the nonresponse group at week 2,week 4,week 12,week 24 during therapy,and at follow-up were(1.21 ±0.15)%,(1.24 ±0.18)%,(1.42 ±0.11)%,(1.45 ±0.11)%,(1.14±0.10)%,respectively,slightly increased(P=0.005) at week 4 during therapy and obviously decreased at followup as regard to previous adjacent time points(P <0.001).Conclusions The kinetics of nTregs during combination therapy of the response group was different from that of the nonresponse group.Significant decline of nTregs at treatment week 2 has close relationship with the early response to ribavirin /pegylated interferon combination therapy.This indicated that nTregs may play a very important role in the early clear of the virus.